Your browser doesn't support javascript.
Reply to Yan and Muller, "Remdesivir for COVID-19: Why Not Dose Higher?"
Juneja, Kavita; Humeniuk, Rita; Porter, Danielle; Cao, Huyen; Feng, Joy.
  • Juneja K; Gilead Sciences, Inc., Foster City, California, USA.
  • Humeniuk R; Gilead Sciences, Inc., Foster City, California, USA.
  • Porter D; Gilead Sciences, Inc., Foster City, California, USA.
  • Cao H; Gilead Sciences, Inc., Foster City, California, USA.
  • Feng J; Gilead Sciences, Inc., Foster City, California, USA joy.feng@gilead.com.
Antimicrob Agents Chemother ; 65(4)2021 03 18.
Article in English | MEDLINE | ID: covidwho-1142995
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: AAC.00085-21

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: AAC.00085-21